EP1126877A4 - Methode zur diagnose, überwachung, feststellung der krankheitsstufe, darstellung und behandlung von prostatakrebs - Google Patents

Methode zur diagnose, überwachung, feststellung der krankheitsstufe, darstellung und behandlung von prostatakrebs

Info

Publication number
EP1126877A4
EP1126877A4 EP99954867A EP99954867A EP1126877A4 EP 1126877 A4 EP1126877 A4 EP 1126877A4 EP 99954867 A EP99954867 A EP 99954867A EP 99954867 A EP99954867 A EP 99954867A EP 1126877 A4 EP1126877 A4 EP 1126877A4
Authority
EP
European Patent Office
Prior art keywords
staging
diagnosing
imaging
monitoring
prostate cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99954867A
Other languages
English (en)
French (fr)
Other versions
EP1126877A1 (de
Inventor
Shujath M Ali
Yongming Sun
Susana Salceda
Herve Recipon
Robert Cafferkey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of EP1126877A1 publication Critical patent/EP1126877A1/de
Publication of EP1126877A4 publication Critical patent/EP1126877A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP99954867A 1998-10-19 1999-10-18 Methode zur diagnose, überwachung, feststellung der krankheitsstufe, darstellung und behandlung von prostatakrebs Withdrawn EP1126877A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10474198P 1998-10-19 1998-10-19
US104741P 1998-10-19
PCT/US1999/023764 WO2000023108A1 (en) 1998-10-19 1999-10-18 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer

Publications (2)

Publication Number Publication Date
EP1126877A1 EP1126877A1 (de) 2001-08-29
EP1126877A4 true EP1126877A4 (de) 2003-05-28

Family

ID=22302121

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99954867A Withdrawn EP1126877A4 (de) 1998-10-19 1999-10-18 Methode zur diagnose, überwachung, feststellung der krankheitsstufe, darstellung und behandlung von prostatakrebs

Country Status (4)

Country Link
EP (1) EP1126877A4 (de)
JP (1) JP2002527757A (de)
CA (1) CA2347085A1 (de)
WO (1) WO2000023108A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ528700A (en) * 1998-04-08 2005-02-25 Genentech Inc Novel PRO866 polypeptides and nucleic acids with homology to mindin and spondin proteins
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EP1466977A1 (de) * 1999-03-08 2004-10-13 Genentech, Inc. Verfahren und Zusammensetzungen zur Inhibierung des neoplastischen Zellwachstums
US6682902B2 (en) 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide
AU8678501A (en) * 2000-08-24 2002-03-04 Genentech Inc Compositions and methods for the diagnosis and treatment of tumor
MXPA06000798A (es) 2003-07-22 2006-04-07 Schering Ag Anticuerpos de rg1 y usos de los mismos.
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045442A2 (en) * 1997-04-10 1998-10-15 Zymogenetics, Inc. Secreted f-spondin homologs

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045442A2 (en) * 1997-04-10 1998-10-15 Zymogenetics, Inc. Secreted f-spondin homologs

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CASTALDO G. ET AL, CLINICA CHIMICA ACTA, vol. 265, no. 1, 1997, pages 65 - 76 *
See also references of WO0023108A1 *

Also Published As

Publication number Publication date
JP2002527757A (ja) 2002-08-27
CA2347085A1 (en) 2000-04-27
EP1126877A1 (de) 2001-08-29
WO2000023108A1 (en) 2000-04-27

Similar Documents

Publication Publication Date Title
EP1239874A4 (de) Methode zur diagnose, überwachung, einstufung, bilddarstellung und behandlung von prostatakrebs
EP1131095A4 (de) Methode zur diagnose, überwachung, feststellung der krankheitsstufe, darstellung und behandlung von prostatakrebs
IL142729A0 (en) Method for improved imaging and photodynamic therapy
AU2001250932A8 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating prostate cancer
AU6688598A (en) Method for diagnosing and staging prostate cancer
GR950100409A (en) Method and apparatus for interstitial radiation of the prostate gland.
MXPA01008794A (es) Metodo para diagnosticar y verificar carcinomas de pecho malignos.
AP2003002875A0 (en) Apparatus and method for treatment of water.
EP0975803A4 (de) Verfahren zur bestimmung von prostatakrebs
GB2345757B (en) Well logging apparatus and method
HUP0203035A3 (en) Compositions and methods for therapy and diagnosis of prostate cancer
AU2001251013A1 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer
GB2344123B (en) Well logging method and apparatus
HUP0000261A3 (en) Means for treating prostate hypertrophy and prostate cancer
EP1267934A4 (de) Neues verfahren zur diagnose, überwachung, statusbestimmung, bildmässiger darstellung und behandlung von brustkrebs
AU2001251223A1 (en) Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer
IL142340A0 (en) Methods for identification, diagnosis, and treatment of breast cancer
AU4003597A (en) Methods of diagnosing and treating cancer
EP1126877A4 (de) Methode zur diagnose, überwachung, feststellung der krankheitsstufe, darstellung und behandlung von prostatakrebs
AU2001268633A1 (en) Method of diagnosing, monitoring, staging, imaging and treating breast cancer
AU2001271621A1 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
AU2001241656A1 (en) Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
NO20014805D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av brystkreft
AU6523901A (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
PL341667A1 (en) Method of treating cooped

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010518

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DIADEXUS, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20030414

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 48/00 B

Ipc: 7A 61K 39/395 B

Ipc: 7C 12Q 1/68 B

Ipc: 7G 01N 33/574 A

17Q First examination report despatched

Effective date: 20030829

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050118